In This Store
Category:Finished Dosage > Anti-tumor Preparations
Product Name:Letrozole Tablets
CAS No.:112809-51-5
Standard:ChP
Price(USD):Negotiable
Company:ZHEJIANG HISUN PHARMACEUTICAL CO.,LTD.
Grade: Pharmaceutical Grade
Factory Location: Taizhou, Zhejiang, P.R.China
Main Sales Markets: Eastern Europe,Asia,Middle East,Africa
Monthly Production Capacity: TBC
Contract Manufacturing: CRO,CMO
Sample Provided: no
Payment Terms: T/T
Letrozole is approved to be used alone or with other drugs to treat:
• Breast cancer in postmenopausal women who have any of the following types of breast cancer--
• Early-stage , hormone receptor–positive (HR+) breast cancer that has been treated.
• Early-stage breast cancer that has been treated with tamoxifen citrate for at least 5 years.
• Breast cancer that is locally advanced or has metastasized (spread to other parts of the body) and is HR+. It is used as the first treatment.
• Breast cancer that is locally advanced or has metastasized and it is not known whether the cancer is HR+ or hormone receptor negative (HR-). It is used as the first treatment.
• Breast cancer that has gotten worse after antiestrogen therapy. It is used as the second treatment.
Letrozole is also being studied in the treatment of other types of cancer.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: